Insider Transactions in Q1 2024 at Maravai Lifesciences Holdings, Inc. (MRVI)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 15
2024
|
Kurt Oreshack General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
4,551
-2.0%
|
$31,857
$7.7 P/Share
|
|
Mar 15
2024
|
Rebecca Buzzeo Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,366
-1.18%
|
$30,562
$7.7 P/Share
|
|
Mar 15
2024
|
Kevin Herde Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,624
-2.53%
|
$60,368
$7.7 P/Share
|
|
Mar 15
2024
|
Peter Michael Leddy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,714
-1.75%
|
$46,998
$7.7 P/Share
|
|
Mar 15
2024
|
Christine Dolan Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,383
-2.04%
|
$37,681
$7.7 P/Share
|
|
Mar 15
2024
|
Carl Hull Director |
SELL
Payment of exercise price or tax liability
|
Direct |
17,560
-6.17%
|
$122,920
$7.7 P/Share
|
|
Feb 15
2024
|
Carl Hull Director |
SELL
Payment of exercise price or tax liability
|
Direct |
10,729
-3.63%
|
$53,645
$5.48 P/Share
|
|
Feb 15
2024
|
Christine Dolan Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,941
-0.73%
|
$9,705
$5.48 P/Share
|
|
Feb 15
2024
|
Kevin Herde Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,664
-0.77%
|
$13,320
$5.48 P/Share
|
|
Feb 15
2024
|
Kurt Oreshack General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
2,322
-1.01%
|
$11,610
$5.48 P/Share
|
|
Jan 16
2024
|
William E. Martin Iii Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
758,415
+42.16%
|
-
|
|
Jan 16
2024
|
Andrew Burch Officer |
BUY
Grant, award, or other acquisition
|
Direct |
295,782
+40.38%
|
-
|
|
Jan 16
2024
|
Kevin Herde Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
250,277
+42.1%
|
-
|
|
Jan 16
2024
|
Kurt Oreshack General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
166,852
+42.02%
|
-
|
|
Jan 16
2024
|
Peter Michael Leddy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
250,277
+39.52%
|
-
|
|
Jan 16
2024
|
Rebecca Buzzeo Officer |
BUY
Grant, award, or other acquisition
|
Direct |
288,198
+43.82%
|
-
|
|
Jan 16
2024
|
Christine Dolan Officer |
BUY
Grant, award, or other acquisition
|
Direct |
189,604
+41.68%
|
-
|
|
Jan 16
2024
|
Carl Hull Director |
BUY
Grant, award, or other acquisition
|
Direct |
75,842
+20.43%
|
-
|